Composition Influence on Pulmonary Delivery of Rifampicin Liposomes

Composition Influence on Pulmonary Delivery of Rifampicin Liposomes

The effects of lipid concentration and composition on the physicochemical properties, aerosol performance and in vitro toxicity activity of several rifampicin-loaded liposomes were investigated. To this purpose, six liposome formulations containing different amounts of soy phosphatidylcholine and hy...

Full description

Bibliographic Details
Main Authors:	Maria Letizia Manca, Chiara Sinico, Anna Maria Maccioni, Octavio Diez, Anna Maria Fadda, Maria Manconi
Format:	Article
Language:	English
Published:	MDPI AG 2012-11-01
Series:	Pharmaceutics
Subjects:	liposomes rifampicin cholesterol oleic acid rheology pulmonary delivery aerosol cell viability cellular uptake
Online Access:	http://www.mdpi.com/1999-4923/4/4/590

Similar Items

Rifampicin–Liposomes for <i>Mycobacterium abscessus</i> Infection Treatment: Intracellular Uptake and Antibacterial Activity Evaluation
by: Federica Rinaldi, et al.
Published: (2021-07-01)

Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model
by: Lucila Garcia-Contreras, et al.
Published: (2021-08-01)

A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis
by: Jagadevappa S Patil, et al.
Published: (2015-01-01)

Following the Fate of Dye-Containing Liposomes In Vitro
by: Jennifer Cauzzo, et al.
Published: (2020-07-01)

Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape
by: Anna Lechanteur, et al.
Published: (2018-04-01)

Effect of Penetration Enhancer Containing Vesicles on the Percutaneous Delivery of Quercetin through New Born Pig Skin
by: Maria Manconi, et al.
Published: (2011-08-01)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
by: Li Y, et al.
Published: (2017-11-01)

Design of Hybrid Gels Based on Gellan-Cholesterol Derivative and P90G Liposomes for Drug Depot Applications
by: Nicole Zoratto, et al.
Published: (2017-05-01)

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
by: Liu HM, et al.
Published: (2017-02-01)

Formulation of a therapeutic cationic liposome-siRNA complex for development to fight osteosarcoma
by: Bibi Fatemeh Haghiralsadat, et al.
Published: (2018-04-01)

In vitro and in vivo Study of a Novel Liposome-Mediated Dual Drug Delivery for Synergistic Lung Cancer Therapy via Oral Administration
by: Zhou Q, et al.
Published: (2020-12-01)

Ligand conjugated liposomal drug delivery system for enhanced brain uptake of ampicillin
by: R. Lala, et al.
Published: (2016-12-01)

Modified Spraying Technique and Response Surface Methodology for the Preparation and Optimization of Propolis Liposomes of Enhanced Anti-Proliferative Activity against Human Melanoma Cell Line A375
by: Hesham Refaat, et al.
Published: (2019-10-01)

Rifampicin-Induced Thrombocytopenia: A Rare Complication
by: Ravi Dosi, et al.
Published: (2019-01-01)

Rifampicin-induced acute thrombocytopenia
by: Banu Rekha V, et al.
Published: (2005-01-01)

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm
by: Anna Gidari, et al.
Published: (2020-08-01)

Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol
by: Pooria Nakhaei, et al.
Published: (2021-09-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al.

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
by: Hui Zhu, et al.
Published: (2015-01-01)

Paramagnetic Liposome Nanoparticles for Cellular and Tumour Imaging
by: Nazila Kamaly, et al.
Published: (2010-04-01)

Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
by: Jeong Moon Choi, et al.
Published: (2011-01-01)

Rapid Quantification and Validation of Lipid Concentrations within Liposomes
by: Carla B. Roces, et al.
Published: (2016-09-01)

Rifampicin induced adrenal crisis in an uncommon setting
by: Animesh Ray, et al.
Published: (2013-01-01)

Influence of isoniazid on the metabolism of rifampicin on rat hepatocytes
by: Fasich Fasich, et al.
Published: (2000-06-01)

MazEF-rifampicin interaction suggests a mechanism for rifampicin induced inhibition of persisters
by: Cyrus Alexander, et al.
Published: (2020-10-01)

Role of Ascorbic Acid in Portal Inflammation Induced by Rifampicin
by: Iram Tassaduq
Published: (2012-06-01)

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
by: M.M. O'Donnel, et al.

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
by: O'Donnel M.M., et al.
Published: (2002-01-01)

Ofloxacin plus Rifampicin versus Doxycycline plus Rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]
by: Kayas Derya, et al.
Published: (2004-06-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Stable, Monodisperse, and Highly Cell-Permeating Nanocochleates from Natural Soy Lecithin Liposomes
by: Martina Asprea, et al.
Published: (2019-01-01)

IN VITRO LUNG EPITHELIAL CELL TRANSPORT AND ANTI-INFLAMMATORY ACTIVITY FOR LIPOSOMAL CIPROFLOXACIN
by: Darweesh, Ruba
Published: (2013)

Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial
by: Daiane Santos dos Santos, et al.
Published: (2018-04-01)

Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?
by: Adriana Aparecida Durães Fonseca, et al.
Published: (2020-07-01)

Detection of Rifampicin Resistance in HIV Seropositive Individuals with Suspected Pulmonary Tuberculosis by Using CBNAAT
by: Shilpa, et al.
Published: (2017-03-01)

“QUALITY BY DESIGN” IN LIPOSOMAL DRUGS CREATION
by: Yu. М. Krasnopolsky, et al.
Published: (2020-12-01)

Liposome-Based Bioassays
by: Jacopo Sforzi, et al.
Published: (2020-08-01)

Fast and Sensitive Voltammetric Method for the Determination of Rifampicin on Renewable Amalgam Film Electrode
by: Marek Szlósarczyk, et al.
Published: (2021-08-01)

Preparation and evaluation of RGD and TAT co-modified docetaxel-loaded liposome
by: Zhu R, et al.
Published: (2017-12-01)